Noile-Immune Biotech Inc. (4893)
Market Closed
5 Oct, 06:00 AM
JPX JPX Primary ¥
117. 00
0
0%
¥
7.01B Market Cap
- P/E Ratio
- Div Yield
93,200 Volume
- Eps
¥ 117
Previous Close Want to track 4893 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Noile-Immune Biotech Inc. (4893) Statistics
Valuation metrics
Market Cap 7.01B
Enterprise value 534.54M
Trailing P/E (ttm) -5.4
Forward P/E -4.41
PEG ratio 0.48
Price/Sales (ttm) 5,705.6
Price/Book (mrq) 1.14
Enterprise Value/Revenue 747.61
Enterprise Value/EBITDA -0.67
Overview
Shares outstanding 43.3M
Float 17M
Shares short -
% Held by insiders 0.58%
% Held by institutions 0.03%
Average volume (10 days) 42.27K
Average volume (90 days) 108.52K
Price summary
52-Week low 114
52-Week high 217
Beta 0.09
50-Day moving average 135.96
200-Day moving average 137.28
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2025
Profitability
Profit margin -1,054.38%
Operating margin -1,125.47%
Operational effectiveness
Return on assets -0.21%
Return on equity -0.2%
Income Statement
Revenue (ttm) 3M
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -1%
Gross profit (ttm) -49M
EBITDA -
Net income to common (ttm) -706M
Diluted EPS (ttm) -17.39
Quarterly earnings growth (yoy) -1%
Balance Sheet
Total cash (mrq) 3.74B
Total cash per share (mrq) 81.78
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 42.73%
Book value per share (mrq) 82.47
Cash Flow
Cash flow statement -755.21M
Levered free cash flow (LFCF) -793.54M
2026 © Marketlog. All Rights Reserved.
